Interestingly, abnormal elevation of hepatic glucose production is known to contribute to fasting hyperglycemia in T2D (Saltiel & Kahn, 2001), and in a diabetic murine model increased gluconeogenesis promoted by FOXO1 seems to be ascribable to decreased FOXP1 expression in the liver. The gene discussed is FOXP1; the disease is Hyperglycemia.